XBI

SPDR S&P BIOTECH ETF $156.20 1M -2.0% 3M +17.7% YTD +28.5% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.7%
Next 1 week
-0.1%
Next 1 month
-1.4%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -5.9% median, 32% of the last 19 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 1
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.32%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.05 -0.2% · Seasonal tilt -1.2%
$1.4B/day volume 28% volatility +66% 1-year -11% from ATH
52-week range · 82% of the way up · -8% from the high
$92.64$169.89

Congressional trades in XBI Full tracker →

6 members · 20 buys / 18 sells · $157K–$830K disclosed · latest filing Aug 10, 2026.

SELL TT Thomas H Tuberville · traded May 8, 2024 $50K–$100K
BUY TT Thomas H Tuberville options · traded May 8, 2024 $1K–$15K
BUY TT Thomas H Tuberville options · traded May 8, 2024 $1K–$15K
SELL JR John F Reed · traded Feb 6, 2025 $1K–$15K
SELL JR John F Reed · traded Jan 22, 2025 $1K–$15K
SELL JR John F Reed · traded Oct 4, 2024 $1K–$15K
SELL DJ David P. Joyce · traded Jun 30, 2023 $15K–$50K
BUY TT Thomas H Tuberville options · traded May 8, 2024 $1K–$15K

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.